Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00101127||Completed||Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma||
||Other / NIH||
||Female||18 Years and older (Adult, Senior)||NCT00101127||GOG-0087L
|December 2003||July 2006||January 10, 2005||February 14, 2014||